CD79B (Polatuzumab Biosimilar) Antikörper
Research Grade
Reaktivität: Human
ELISA, FACS
Wirt: Humanized
Monoclonal
unconjugated
1 image
-
- Target
- CD79B (Polatuzumab Biosimilar)
- Reaktivität
- Human
-
Wirt
-
Humanized
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD79B (Polatuzumab Biosimilar) Antikörper ist unkonjugiert
- Applikation
- ELISA, Flow Cytometry (FACS)
- Verwendungszweck
- Anti-CD79B(polatuzumab biosimilar) mAb
- Produktmerkmale
- RO5541077, RG-7596
- Güteklasse
- Research Grade
- Isotyp
- IgG1
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
- Haltbarkeit
- 12 months
-
- Target
- CD79B (Polatuzumab Biosimilar)
- Substanzklasse
- Biosimilar
- Hintergrund
- B29,IGB
- UniProt
- P40259
-
Sie sind hier:
